Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.

Alberto PapiJonathan CorrenMario CastroChristian DomingoLinda RogersKenneth R ChapmanDaniel J JacksonNadia DaizadehNami Pandit-AbidRebecca GallJuby A Jacob-NaraPaul J RoweYamo DenizBenjamin Ortiz

Published in: Allergy (2022)

Dupilumab treatment led to improvements in lung function independent of exacerbations and appeared to reduce the impact of exacerbations on lung function in patients who experienced a severe exacerbation during the study.

Keyphrases

lung function
chronic obstructive pulmonary disease
cystic fibrosis
early onset
atopic dermatitis
air pollution
drug induced
high intensity
acute respiratory distress syndrome
combination therapy
extracorporeal membrane oxygenation
mechanical ventilation